| Not Yet Recruiting | Shared Decision Making for Antipsychotic Medications NCT05416658 | New York State Psychiatric Institute | N/A |
| Not Yet Recruiting | Brain Network Mechanisms of Cognitive Impairments in Major Psychiatric Disorders and Their Clinical Applicatio NCT07444463 | Central South University | N/A |
| Not Yet Recruiting | Prucalopride for Cognitive Functioning in Schizophrenia NCT06474286 | University of Pittsburgh | N/A |
| Not Yet Recruiting | Enhancing Veteran-Clinical Collaboration in VA PRRCs NCT06898879 | VA Office of Research and Development | N/A |
| Not Yet Recruiting | Evaluate Pharmacokinetics, Safety, and Tolerability of AX251 LAI in Patients With Schizophrenia NCT07484204 | Anxo Pharmaceutical Co., Ltd. | Phase 1 |
| Not Yet Recruiting | Digital Implementation Support to Achieve Uptake and Integration of Task-Shared Care for Schizophrenia in Prim NCT06043778 | Harvard Medical School (HMS and HSDM) | N/A |
| Not Yet Recruiting | Impact of Cannabis Consumption on Psychotic Symptoms and Reality Monitoring in Patients With Schizophrenia: a NCT07309159 | Centre Hospitalier Charles Perrens, Bordeaux | Phase 1 / Phase 2 |
| Not Yet Recruiting | Feasibility and Acceptability of Mobile Mental Health App for SZ and SZA NCT06474325 | University of Pittsburgh | N/A |
| Not Yet Recruiting | Mobile Thinking Intervention: A Inital Test NCT06909422 | University of Alabama at Birmingham | N/A |
| Not Yet Recruiting | Venous Tourniquet vs. Arterial Tourniquet for Seizure Monitoring in ECT NCT07534475 | Medipol University | N/A |
| Not Yet Recruiting | 52-week Open Label Safety-Tolerability Study NCT07369154 | LB Pharmaceuticals Inc. | Phase 3 |
| Not Yet Recruiting | Emotional Eating, Sleep Quality, Mental State and Metabolic Syndrome NCT07411222 | Abant Izzet Baysal University | — |
| Not Yet Recruiting | REACH Study (Recovery Environments: Assessing Cognitive & Brain Health in Community Mental Health) NCT07006935 | Case Western Reserve University | N/A |
| Not Yet Recruiting | A Phase 2 Study to Evaluate the Efficacy and Safety of LY03020 in Acutely Psychotic Participants With Schizoph NCT07396870 | Luye Pharma Group Ltd. | Phase 2 |
| Recruiting | A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophre NCT07424404 | Karuna Therapeutics, Inc., a Bristol Myers Squibb company | Phase 3 |
| Recruiting | Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia NCT07363577 | LB Pharmaceuticals Inc. | Phase 3 |
| Not Yet Recruiting | A Study to Detect the Radioactivity of 14C-SEP-380135 in Urine and Feces in Healthy Male Adults NCT07455084 | Otsuka Pharmaceutical Development & Commercialization, Inc. | Phase 1 |
| Recruiting | Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizop NCT07467993 | Novartis Pharmaceuticals | Phase 2 |
| Not Yet Recruiting | A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia NCT07459647 | MapLight Therapeutics | Phase 2 |
| Recruiting | Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT) NCT07379827 | Bristol-Myers Squibb | — |
| Not Yet Recruiting | Effectiveness of Exercise Alone and tDCS+Exercise on Cognitive Function Improvement in Patients With Treatment NCT07404319 | Kit Wa Chan | N/A |
| Recruiting | Evaluation of NBI-1117570 in Inpatient Adults With Schizophrenia NCT07288333 | Neurocrine Biosciences | Phase 2 |
| Not Yet Recruiting | PQQ for Cognitive and Negative Symptoms NCT07393464 | Tianjin Anding Hospital | N/A |
| Recruiting | A Study of Brenipatide in Adult Participants With Schizophrenia NCT07410507 | Eli Lilly and Company | Phase 2 |
| Recruiting | TMS for Inhibition Enhancement in Schizophrenia NCT06155682 | University of Maryland, Baltimore | N/A |
| Recruiting | CBT-CP for Veterans With SMI NCT06758414 | VA Office of Research and Development | N/A |
| Recruiting | Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Sp NCT07395206 | Charite University, Berlin, Germany | N/A |
| Recruiting | A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGE NCT07288567 | Bristol-Myers Squibb | Phase 3 |
| Recruiting | A Study to Evaluate the Effect of KarXT on Urological Safety NCT07221877 | Bristol-Myers Squibb | Phase 4 |
| Recruiting | Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia NCT07196462 | Vanderbilt University Medical Center | N/A |
| Not Yet Recruiting | Impact of Medication Education on Adherence and Side Effects NCT07374588 | Cumhuriyet University | N/A |
| Not Yet Recruiting | Intermittent Theta Burst Stimulation of the Precuneus NCT06142422 | GCS Ramsay Santé pour l'Enseignement et la Recherche | N/A |
| Not Yet Recruiting | Bromocriptine for Patients With Schizophrenia and Prediabetes NCT03575000 | VA Pittsburgh Healthcare System | Phase 4 |
| Recruiting | A Long-term Administration Trial of SEP-363856 in Patients With Schizophrenia NCT07225712 | Otsuka Pharmaceutical Co., Ltd. | Phase 3 |
| Recruiting | Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia NCT07227818 | Neurocrine Biosciences | Phase 3 |
| Recruiting | Early Identification of Patients Presenting a First Psychotic Episode, Non Answering to First Line Support Str NCT02670447 | Centre Hospitalier Universitaire de Saint Etienne | — |
| Recruiting | Investigating Mediodorsal Thalamus Representations Underlying Human Cognitive Flexibility NCT07217652 | Kai Hwang | N/A |
| Withdrawn | Lifestyle MIND- Feasibility of Wait-list Control NCT06384521 | The University of Texas Health Science Center at San Antonio | N/A |
| Withdrawn | Pharmacologic Treatment in Legal Offenders With Schizophrenia, a Prospective Observational Mirror Image Study. NCT05939765 | Psychiatric University Hospital, Zurich | — |
| Enrolling By Invitation | Mindfulness-Based Therapy for Serious Mental Illness NCT06880796 | Butler Hospital | N/A |
| Recruiting | Group Intervention for Romantic Relationships in Young Adults With Severe Mental Illness NCT07316803 | Centre hospitalier de Ville-Evrard, France | N/A |
| Completed | Effect of Curcumin Add-On Therapy on Quality of Life and IL-1β Levels in Patients With Schizophrenia NCT07523256 | Rinvil Renaldi | N/A |
| Recruiting | Biomarker Research on Ultra-High-Field MRI Combined With Visual Perception Assessment in the Diagnosis and Tre NCT07479758 | Second Affiliated Hospital, School of Medicine, Zhejiang University | — |
| Not Yet Recruiting | This Hospital-based Observational Study Employed a Study Will be Conducted in Sohag University Hospital Clinic NCT07184710 | Sohag University | — |
| Recruiting | Personalized iTBS in Real-World Clinical Settings for Schizophrenia NCT07176468 | Anhui Medical University | N/A |
| Completed | Effectiveness of Traditional Chinese Metacognitive Training (MCT) in Patients With Schizophrenia, Depression, NCT07051746 | ZI-YU LIN | N/A |
| Not Yet Recruiting | Efficacy and Functional Recovery After Switching From Paliperidone Palmitate Injection to Oral Antipsychotics NCT07075237 | Jiangsu Province Nanjing Brain Hospital | Phase 4 |
| Recruiting | Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU) NCT07101094 | Bristol-Myers Squibb | — |
| Recruiting | Sex Differences in NMDA-enhancing Treatment of Schizophrenia NCT07122895 | China Medical University Hospital | Phase 2 |
| Recruiting | Role of Inferior Colliculi in Auditory Hallucinations NCT07003529 | Centre Hospitalier Universitaire de Nīmes | N/A |
| Recruiting | A Study to Evaluate the Dose Levels, Safety, and Drug Levels of Single KarXT Intramuscular Injection in Partic NCT07061288 | Bristol-Myers Squibb | Phase 1 |
| Not Yet Recruiting | Approaches For ThE pRioritization of Patients in priMAry Care Post-COVID To Reduce Health Inequities (AFTERMAT NCT05823805 | Unity Health Toronto | N/A |
| Not Yet Recruiting | Efficacy and Safety of Paliperidone in Schizophrenia - Bangladesh Study NCT07153835 | Sher-E-Bangla Medical College | Phase 4 |
| Recruiting | A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Re NCT07105111 | Neurocrine Biosciences | Phase 4 |
| Recruiting | A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020 NCT07230652 | Luye Pharma Group Ltd. | Phase 1 |
| Not Yet Recruiting | Value of Voxel-Based Morphometry in Schizophrenia NCT07108673 | Assiut University | — |
| Recruiting | NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia NCT07105098 | Neurocrine Biosciences | Phase 3 |
| Recruiting | A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body NCT07145918 | AbbVie | Phase 2 |
| Recruiting | Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Ca NCT07185815 | Mapi Pharma Ltd. | Phase 1 / Phase 2 |
| Active Not Recruiting | A Food Effect Study of LY03020 in Healthy Subjects NCT07292233 | Luye Pharma Group Ltd. | Phase 1 |
| Not Yet Recruiting | Therapeutic Improvement in People With Schizophrenia Undergoing tACS/CBTp (Transcranial Alternating Current St NCT06889025 | Felicia Iftene | N/A |
| Recruiting | NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia NCT07114874 | Neurocrine Biosciences | Phase 3 |
| Not Yet Recruiting | A Clinical Trial of Adjunctive Thyroxine for Avolition in Schizophrenia NCT07011953 | Peking University | EARLY_Phase 1 |
| Recruiting | Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients NCT07045142 | Central South University | Phase 3 |
| Not Yet Recruiting | Ketogenic Metabolic Therapy in Schizophrenia, Bipolar Disorder, Major Depressive Disorder: Deep Omic Profiling NCT06748950 | Stanford University | N/A |
| Recruiting | A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophren NCT07038876 | MapLight Therapeutics | Phase 2 |
| Completed | Bioequivalence Study to Compare Brexpiprazole 4 mg Film Coated Tablets Versus RXULTI 4 mg Film Coated Tablet ( NCT07266792 | Humanis Saglık Anonim Sirketi | Phase 1 |
| Completed | Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder NCT07116694 | BioXcel Therapeutics Inc | Phase 2 |
| Recruiting | Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave NCT06890208 | Universitätsklinikum Hamburg-Eppendorf | — |
| Recruiting | A Study to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Participants With Sch NCT06882785 | Bristol-Myers Squibb | Phase 3 |
| Recruiting | Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 2) NCT06961916 | The University of Texas Health Science Center, Houston | N/A |
| Active Not Recruiting | The Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective. NCT06993662 | Rakitzi, Stavroula | Phase 1 |
| Recruiting | A Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With Schizop NCT06821945 | Boryung Pharmaceutical Co., Ltd | Phase 2 |
| Enrolling By Invitation | The Effect of an Individual Empowerment Program Provided to Relatives of Schizophrenia Patients NCT07173192 | Istanbul Arel University | N/A |
| Recruiting | Randomized Withdrawal Study in Patients With Schizophrenia NCT06961968 | Vanda Pharmaceuticals | Phase 3 |
| Recruiting | NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia NCT06963034 | Neurocrine Biosciences | Phase 3 |
| Recruiting | Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder NCT06939088 | Anders Fink-Jensen, MD, DMSci | Phase 2 |
| Not Yet Recruiting | The Effect of Logotherapy-Based Psychoeducation Applied to Family Members of Individuals Diagnosed with Schizo NCT06859112 | aslı zeynep sipahi | N/A |
| Not Yet Recruiting | Study on the Efficacy and Safety of QLM1016 in Schizophrenia NCT06799559 | Qilu Pharmaceutical Co., Ltd. | Phase 3 |
| Recruiting | Magnetic Seizure Therapy for Schizophrenia - Trial NCT06672588 | Centre for Addiction and Mental Health | N/A |
| Completed | Effect of Psychoeducation -Based Motivational Interviewing on Knowledge and Hope in Schizophrenia NCT07365982 | Büşra Taşkıner | N/A |
| Withdrawn | A Study to Evaluate the Safety and Tolerability of Long-Acting Oral Risperidone (LYN-005) in Participants With NCT06878833 | Lyndra Inc. | Phase 3 |
| Not Yet Recruiting | An Open-Label Study to Evaluate the Efficacy and Tolerability of Xanomeline/Trospium In First Episode/Early Ph NCT06923891 | Vanguard Research Group | Phase 4 |
| Recruiting | Tolerability of MDMA in Schizophrenia NCT05770375 | Anya Bershad, MD, PhD | Phase 1 / Phase 2 |
| Completed | A Trial to Test the Effects of Other Drugs on SEP-380135 in Healthy Men and Women NCT07305779 | Otsuka Pharmaceutical Development & Commercialization, Inc. | Phase 1 |
| Recruiting | A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia NCT06894212 | Otsuka Pharmaceutical Development & Commercialization, Inc. | Phase 3 |
| Recruiting | Enhancing Rehabilitation for Veterans With Serious Mental Illness NCT06586164 | VA Office of Research and Development | N/A |
| Not Yet Recruiting | The Effect of Salutogenic-based Interviewing on Subjective Recovery and Quality of Life in Schizophrenia NCT06820580 | Ataturk University | N/A |
| Recruiting | Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial NCT06456983 | Central Institute of Mental Health, Mannheim | N/A |
| Recruiting | RTMS for Refractory Auditory Hallucinations Based on Personalized Targets Using Magnetoencephalography NCT06802939 | Shanghai Mental Health Center | N/A |
| Recruiting | The Effects of Auditory Stimulation During Sleep on Brain Networks in Schizophrenia NCT06386588 | Massachusetts General Hospital | N/A |
| Not Yet Recruiting | Improving Real-world Function for Persons with Schizophrenia: a Single-case Experimental Design NCT06790186 | Sykehuset Innlandet HF | N/A |
| Recruiting | Anticholinergic Deprescription in Schizophrenia NCT06562608 | Deepak K. Sarpal, M.D. | Phase 4 |
| Withdrawn | Evaluation Study of New Compounds With Potential Use in Schizophrenia NCT00916201 | Central Institute of Mental Health, Mannheim | Phase 1 |
| Recruiting | Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness NCT06376734 | Brigham and Women's Hospital | Phase 2 |
| Not Yet Recruiting | Investigation of Objective Cognitive Effort in Neuropsychological Evaluation of Psychotic Disorders NCT06782672 | University Hospital, Montpellier | — |
| Active Not Recruiting | A Prospective Cohort Study to Assess Clinical Effectiveness of an Investigational Digital Therapeutic (CT-155) NCT06791122 | Boehringer Ingelheim | N/A |
| Recruiting | Immunoinflammatory State Detection and Multimodal Brain Imaging and Electrophysiologic Changes in Schizophreni NCT06673966 | Central South University | — |
| Recruiting | Decision-Making in Schizophrenia: A Combined Neuroimaging and Experience Sampling Study NCT06745479 | Rutgers, The State University of New Jersey | N/A |
| Not Yet Recruiting | From Brain Currents to Interpersonal Flow: Investigating the Social Processing Stream of Schizophrenia NCT03543553 | Oslo University Hospital | — |
| Withdrawn | Brain Biomarker on Inflammation Response NCT03271814 | University of Maryland, Baltimore | Phase 1 |
| Not Yet Recruiting | Obstructive Sleep Apnea Treatment in Serious Mental Illness NCT05457127 | University of California, San Diego | N/A |
| Completed | Mindfulness Psychoeducation for Schizophrenia NCT07310615 | Ömer USLU | N/A |
| Active Not Recruiting | Imagery Rescripting as a Treatment for Early Psychosis NCT06539780 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | N/A |
| Not Yet Recruiting | Individual Placement and Support and/or Cognitive Remediation Therapy Added to TAU in Patients With Early Schi NCT03974620 | Pakistan Institute of Living and Learning | N/A |
| Completed | Supportive Psychotherapy as Adjunct to Risperidone for Cognitive Function and Inflammation in Schizophrenia NCT07477301 | Hasanuddin University | Phase 2 |
| Withdrawn | The Sub-Sero Study NCT03994965 | Bjorn H. Ebdrup | Phase 2 |
| Recruiting | nTMS for Negative Symptom in Schizophrenia NCT06642675 | Central South University | N/A |
| Active Not Recruiting | Neuro-VR: Augmenting a Virtual Reality-based Therapy With Biofeedback for Auditory Hallucinations NCT06628323 | University Hospital Bispebjerg and Frederiksberg | N/A |
| Recruiting | Study of Intra- and Interpersonal Multimodal Synchronizations in a Social Interaction in Individuals with a Di NCT06484387 | University Hospital, Montpellier | N/A |
| Not Yet Recruiting | A Study of Olanzapine-Samidorphan Tablets in Adults With Schizophrenia NCT06649214 | Qilu Pharmaceutical Co., Ltd. | Phase 3 |
| Completed | Study to Assess Safety and Effectiveness of Slowly Increasing Dose and Food Effect of KarXT in Participants Wi NCT06572449 | Karuna Therapeutics, Inc., a Bristol Myers Squibb company | Phase 3 |
| Terminated | Correlates of Fatigue in People With Schizophrenia NCT06397950 | GCS CIPS | — |
| Recruiting | A Bioequivalence Study of PP3M in Patients With Schizophrenia NCT07493551 | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | N/A |
| Recruiting | Voice-Based Biomarkers: a Novel Approach to Monitoring and Predicting Schizophrenia Relapses NCT06613334 | Centre Hospitalier St Anne | N/A |
| Not Yet Recruiting | Functional Magnetic Resonance Imaging Study in Schizophrenia Patients and Correlation With Cognitive Impairmen NCT06471179 | Assiut University | — |
| Not Yet Recruiting | The Personalized Psychological Treatment for Psychosis NCT06603922 | Polish Academy of Sciences | N/A |
| Not Yet Recruiting | Exploring the Effectiveness of Digital Anti-stigma Therapy on Illness Perception and Perceived Stigma in Patie NCT06563752 | National Yang Ming Chiao Tung University | N/A |
| Recruiting | Dual Modulation of Sigma-1 and NMDA Receptors in the Treatment of Schizophrenia NCT06574360 | China Medical University Hospital | Phase 2 |
| Recruiting | A Study on the Preference of Risperidone Dosage Forms NCT06657430 | Shanghai Mental Health Center | — |
| Recruiting | Genetics of Cannabis Use Disorder and Cannabinoid Response in Humans NCT06058702 | Yale University | Phase 1 |
| Enrolling By Invitation | Accelerated DMN-Targeted cTBS to Modulate DMN Connectivity NCT07155096 | Vanderbilt University Medical Center | N/A |
| Recruiting | Autonomic Nervous System and Meridian Energy in Patients With Schizophrenia NCT06617104 | National Taiwan University Hospital | — |
| Recruiting | Taking Action for College Students NCT06700902 | Temple University | N/A |
| Not Yet Recruiting | A Biological Signature for the Early Differential Diagnosis of Psychosis NCT06515522 | IRCCS San Raffaele | — |
| Completed | A Study Assessing the Safety and Tolerability of LY03020 in Chinese Healthy Subjects NCT06556966 | Luye Pharma Group Ltd. | Phase 1 |
| Recruiting | Integrative Neuro-social Cognitive Strategy Programme for Instilling REcovery (INSPIRE) a Community-Based Cogn NCT06286202 | Singapore Institute of Technology | N/A |
| Active Not Recruiting | Study of SPG302 in Adults With Schizophrenia NCT06442462 | Spinogenix | Phase 2 |
| Not Yet Recruiting | Assessment of Schizophrenia Patients' Clinical Study Experiences NCT05948111 | Power Life Sciences Inc. | — |
| Recruiting | Cerebellar Modulation of Cognition in Psychosis NCT06107764 | Mclean Hospital | N/A |
| Recruiting | Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119 NCT06504290 | Vigonvita Life Sciences | Phase 1 |
| Completed | Pharmacokinetic Study of VHX-896 and Iloperidone Tablets Under Steady-State Conditions NCT06494397 | Vanda Pharmaceuticals | Phase 1 |
| Recruiting | Sensory and Cognitive Predictions, and Their Disruptions in Schizophrenia NCT06361407 | Centre Psychothérapique de Nancy | N/A |
| Active Not Recruiting | Cue-based Intervention in Prospective Memory and Medication Adherence. NCT06474195 | University of Pittsburgh | N/A |
| Recruiting | Study of ALTO-101 in Patients With Schizophrenia NCT06502964 | Alto Neuroscience | Phase 2 |
| Recruiting | Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms. NCT06482554 | Louisiana State University Health Sciences Center Shreveport | Phase 3 |
| Recruiting | Cognitive Remediation in Schizophrenia: Efficacy and Role of Neuroplasticity in "Top-down" and "Bottom-up" Mec NCT06482918 | University of Chile | N/A |
| Not Yet Recruiting | An In Depth Study Evaluating The Experiences of Patients In Schizophrenia Research NCT05870722 | Power Life Sciences Inc. | — |
| Completed | EVEN - Effects of VR on Empathy for Nature in Patients with Psychosis and Depressive Disorders NCT06446856 | Charite University, Berlin, Germany | — |
| Recruiting | Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1) NCT06345963 | The University of Texas Health Science Center, Houston | N/A |
| Completed | Chronical Illness-related Limitations of the Ability to Cope with Rising Temperatures: an Observational Study, NCT06407154 | Universitätsklinikum Hamburg-Eppendorf | — |
| Recruiting | Low-dose Buprenorphine as a Modulator of Social Motivation in Schizophrenia NCT05778591 | University of California, Los Angeles | Phase 2 |
| Unknown | Qualitative Study of Emotional Regulation in Schizophrenia NCT06275451 | University Hospital, Grenoble | — |
| Completed | An Exploratory, Double-arm, 8-week Study to Explore the Feasibility and Acceptability of Abbreviated Treatment NCT06486948 | Click Therapeutics, Inc. | N/A |
| Completed | Physical Exercise on Simple Inflammatory Markers, Systemic Immune Inflammation Index, and Systemic Immune Resp NCT06574893 | Dr. Lutfi Kirdar Kartal Training and Research Hospital | N/A |
| Active Not Recruiting | Profiling Vulnerability and Resilience for Mental Illness Following Viral Infections NCT06945627 | Sara Poletti | — |
| Unknown | The Effect of Psychoeducation Focused on Reducing Internalized Stigma NCT06347848 | Istanbul University - Cerrahpasa | N/A |
| Recruiting | Anti-Inflammatory Challenge in Schizophrenia NCT05823532 | Emory University | Phase 4 |
| Recruiting | Effectiveness of Motivation Skills Training (MST) NCT05805397 | Columbia University | N/A |
| Unknown | Neurotransmitters in Treatment Resistant Schizophrenia Patients With add-on Sodium Benzoate NCT06340789 | National Cheng-Kung University Hospital | Phase 2 |
| Completed | Atypical Antipsychotic-induced Mitochondrial Dysfunction in Patients With Schizophrenia NCT06236451 | All India Institute of Medical Sciences, Bhubaneswar | Phase 4 |
| Recruiting | Efficacy and Safety of tACS vs tDCS in Schizophrenia NCT06494124 | All India Institute of Medical Sciences, Bhubaneswar | N/A |
| Recruiting | Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia NCT06174116 | University of Massachusetts, Worcester | Phase 4 |
| Recruiting | Effect of Neuroplasticity Modulation in tDCS Treatment Response Among Schizophrenia Patients With Auditory Hal NCT04629352 | National Institute of Mental Health and Neuro Sciences, India | N/A |
| Not Yet Recruiting | Combining Clemastine and Aerobic Exercise to Treat Cognitive Dysfunction in Schizophrenia by Targeting Myelin NCT06315972 | LMU Klinikum | Phase 2 |
| Recruiting | The Hi-tACS on Cognitive Function in Patients With Schizophrenia NCT06470516 | Sir Run Run Shaw Hospital | N/A |
| Completed | Safety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With Schizophrenia NCT06253546 | Teva Branded Pharmaceutical Products R&D, Inc. | Phase 1 |
| Unknown | The Effect of Acceptance and Commitment Therapy Intervention on Caregiver Burden in Caregivers of Schizophreni NCT06799325 | Cumhuriyet University | N/A |
| Unknown | Hippotherapy in Patients With Schizophrenia NCT06303596 | Erzurum Technical University | N/A |
| Completed | Culture and Well-being: Art as Prescription Therapy ("Art on Prescription") NCT06361667 | KAVADIA ELENI | N/A |
| Active Not Recruiting | Optimizing CBSST With Executive Function Training for Schizophrenia NCT06251193 | University of California, San Diego | N/A |
| Completed | An Open-Label Trial to Assess the Comparative Bioavailability of TV-44749 to Oral Olanzapine in Participants W NCT06315283 | Teva Branded Pharmaceutical Products R&D LLC | Phase 1 |
| Active Not Recruiting | Young Adults With Violent Behavior During Early Psychosis (Aim 2) NCT05756855 | Columbia University | N/A |
| Completed | Exploring the Health Effects of Group Game-based Activities on Individuals With Chronic Mental Illness NCT06440200 | National Taiwan University Hospital | N/A |
| Active Not Recruiting | A Study of ANAVEX3-71 in Adults With Schizophrenia NCT06245213 | Anavex Life Sciences Corp. | Phase 2 |
| Recruiting | Effect of Exercise on Clinical Symptoms, Cognitive Performance, and Quality of Life in Schizophrenia Patients NCT06573320 | Dr. Lutfi Kirdar Kartal Training and Research Hospital | N/A |
| Recruiting | Characterization of High-Level Cognitive Impairments in Patients With Neuropsychiatric Disorders NCT07295652 | Centre Hospitalier St Anne | N/A |
| Recruiting | Prediction and Intervention Effect of Rehabilitation Status for Severe Mental Disorder Patients Based on Multi NCT06904079 | Shanghai Mental Health Center | N/A |
| Active Not Recruiting | Investigating the Muscarinic System in Schizophrenia Using Positron Emission Tomography NCT06278246 | Centre for Addiction and Mental Health | — |
| Completed | Kombucha Tea for Improving Defecation in Patients With Schizophrenia- a Randomized Controlled Study NCT06502509 | TsaoTun Psychiatric Center, Department of Health, Taiwan | N/A |
| Recruiting | Energetics and Glutamate in Schizophrenia NCT06236048 | King's College London | — |
| Unknown | The Phase I Study of HS-10509 in Chinese Adult Subjects NCT06301074 | Jiangsu Hansoh Pharmaceutical Co., Ltd. | Phase 1 |
| Not Yet Recruiting | Impact of tDCS on Cannabis Craving in Schizophrenia NCT05784961 | Centre hospitalier de Ville-Evrard, France | N/A |
| Unknown | Physical Exercise in Patients With Schizophrenia NCT05978921 | University of Salamanca | N/A |
| Not Yet Recruiting | Stratifying Psychoses for Personalized REpetitive TMS in Persistent NEgative Symptoms Alleviation NCT06184165 | University Hospital, Strasbourg, France | N/A |
| Not Yet Recruiting | HD-tDCS for Hallucinations NCT06208176 | Hôpital le Vinatier | N/A |
| Recruiting | The Danish Region Midt Schizophrenia Cohort NCT06431009 | University of Aarhus | — |
| Enrolling By Invitation | Tryptophan-Kynurenine Pathway Metabolism in the Pathophysiology of Cognitive Impairment in Schizophrenia. NCT07162467 | Tianjin Anding Hospital | — |
| Recruiting | Getting Out of the House: Using Behavioral Activation to Increase Community Participation NCT06336616 | Temple University | N/A |
| Completed | Comparison of the Effects of Aerobic Exercise and Computerized Cognitive Stimulation in Patients With Schizoph NCT06572657 | Dr. Lutfi Kirdar Kartal Training and Research Hospital | N/A |
| Recruiting | Enhanced Coordinated Specialty Care for Early Psychosis NCT06071858 | Mclean Hospital | N/A |
| Recruiting | Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Au NCT06229210 | Intra-Cellular Therapies, Inc. | Phase 3 |
| Terminated | C-Cog in Early Course Schizophrenia Study NCT05662306 | University of Miami | Phase 4 |
| Recruiting | Study of Language Disorders and Interactions Between Mnesic Capabilities and Semantic Competencies in Patients NCT06036316 | Centre Psychothérapique de Nancy | N/A |
| Completed | CAE for Poorly Adherent Individuals With Schizophrenia NCT06061952 | University Hospitals Cleveland Medical Center | N/A |
| Completed | Baduanjin Versus Brisk Walking for Cognition in Schizophrenia NCT06226779 | Chang Gung Memorial Hospital | N/A |
| Terminated | Horyzons: Implementation and Integration in Clinical Practice NCT06002958 | University of North Carolina, Chapel Hill | N/A |
| Completed | The Personal Recovery Based Psychoeducation For Schizophrenia NCT06284096 | Istanbul University - Cerrahpasa | N/A |
| Not Yet Recruiting | Norwegian Adult Mental Health Registry NCT06115200 | Helse Stavanger HF | — |
| Recruiting | Establishing a Clinical Database and Biobank for Schizophrenia：A Cohort Study NCT06123897 | Central South University | — |
| Completed | A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of KYN-5356 in Healthy Subjects Aged 18 NCT06225115 | Kynexis B.V. | Phase 1 |
| Completed | Bioequivalence Study of Long-Acting Paliperidone Palmitate in Patients With Schizophrenia NCT07268430 | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | N/A |
| Active Not Recruiting | The Protein Disrupted in Schizophrenia 1 (DISC1) as a Novel Biomarker for Cardiac Disease NCT06304233 | Norwegian University of Science and Technology | — |
| Recruiting | Validation of the Lithuanian Version of the BNSS, CDSS, and the SCoRS NCT06278532 | Lithuanian University of Health Sciences | — |
| Recruiting | Accelerated Transcranial Magnetic Stimulation for People With Schizophrenia Treated With Clozapine NCT06003036 | Deepak K. Sarpal, M.D. | N/A |
| Completed | Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute Sc NCT06179108 | LB Pharmaceuticals Inc. | Phase 2 |
| Recruiting | The Hi-tACS on Cognitive Function in Patients With Schizophrenia: a Pilot Study NCT06231732 | Sir Run Run Shaw Hospital | N/A |
| Completed | NST-SPARK: Preliminary Study of an Augmented Reality (AR) App Delivering Recovery-Oriented Cognitive Therapy f NCT06653829 | North Shore Therapeutics, Inc. | N/A |
| Unknown | Personalized Prospective Study Evaluation of the Efficacy and Safety of Noninvasive Neuromodulation of TMS in NCT06176456 | Moscow Psychiatric Hospital No. 1 Named after N.A. Alexeev | N/A |
| Unknown | Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Ana NCT06060886 | Consorcio Centro de Investigación Biomédica en Red (CIBER) | Phase 4 |
| Recruiting | App and Body Fat Scale in the Management of Overweight Patients NCT05866107 | Capital Medical University | N/A |
| Recruiting | Study of the Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules in Chinese Healthy Volu NCT06105151 | Vigonvita Life Sciences | Phase 1 |
| Recruiting | NMDA-enhancing Treatment for Cognitive Dysfunction of Schizophrenia NCT06021197 | China Medical University Hospital | Phase 2 |
| Recruiting | Neuromodulation for Schizophrenia NCT05580211 | Scion NeuroStim | N/A |
| Completed | Food Effect Study of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia NCT06036108 | Otsuka Pharmaceutical Co., Ltd. | Phase 1 |
| Completed | Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Di NCT06041646 | BioXcel Therapeutics Inc | Phase 4 |
| Completed | iTEST: Introspective Accuracy as a Novel Target for Functioning in Psychotic Disorders NCT05899348 | University of California, San Diego | N/A |
| Terminated | Alexithymia Intervention for Suicide NCT05724953 | VA Office of Research and Development | Phase 1 |
| Enrolling By Invitation | Effects of Transcranial Direct Current Stimulation on Cognitive Rehabilitation in Schizophrenia NCT07273175 | Medical University of Lodz | N/A |
| Recruiting | Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical NCT05956327 | LMU Klinikum | N/A |
| Completed | Pharmacokinetics, Safety and Tolerability of Different Formulations and Dose Strengths of Quarterly Risperidon NCT06276361 | Rovi Pharmaceuticals Laboratories | Phase 1 |
| Enrolling By Invitation | Berberine in Treating Negative Symptoms of Schizophrenia: Clinical Efficacy and Mechanisms NCT07356765 | Tianjin Anding Hospital | N/A |
| Recruiting | Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psyc NCT06197048 | Vestre Viken Hospital Trust | N/A |
| Unknown | Study on the Bioequivalence of Amisulpride Orally Disintegrating Tablets in Human Body NCT06066112 | The Affiliated Hospital of Qingdao University | Phase 1 |
| Completed | A Study to Evaluate the Overall Effects of Treatment With Abbreviated CT-156 in People With Schizophrenia NCT06136936 | Click Therapeutics, Inc. | N/A |
| Completed | A Study of MK-5720 in Participants With Schizophrenia (MK-5720-001) NCT05953740 | Merck Sharp & Dohme LLC | Phase 1 |
| Completed | An Extension Study of a Second Course of a Digital Therapeutic for the Treatment of Experiential Negative Symp NCT06067984 | Click Therapeutics, Inc. | Phase 3 |
| Terminated | The Effects of Non-invasive Neuromodulation on Illness Awareness in Schizophrenia NCT05957484 | Centre for Addiction and Mental Health | N/A |
| Active Not Recruiting | Ketogenic Diet in People With Schizophrenia NCT05968638 | University of Maryland, Baltimore | N/A |
| Recruiting | The Efficacy of Metacognitive Skills Training in the Context of Forensic Psychiatric Care NCT06005766 | University of Jyvaskyla | N/A |
| Withdrawn | Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in t NCT05974527 | Brigham and Women's Hospital | Phase 4 |
| Recruiting | Sex, Psychopharmacology, and Diabetes NCT05951660 | Zealand University Hospital | N/A |
| Completed | Long-acting Injectable Antipsychotics for Mental Ill-Health in Pregnancy and Postpartum NCT05766007 | University of Liverpool | — |
| Completed | Technology-Assisted Implementation of a Mobile Health Program for Serious Mental Illness NCT05725785 | University of Washington | N/A |
| Recruiting | iTBS for Increased Appetite Induced by Antipsychotics NCT05783063 | Central South University | N/A |
| Recruiting | Examining the Efficacy of a Virtual Reality Cognitive Remediation Program for People Living With Psychosis NCT05973110 | The Royal Ottawa Mental Health Centre | N/A |
| Unknown | Safety, Tolerability, Pharmacokinetics and Efficacy Study of HS-10380 in Patients With Schizophrenia NCT05964790 | Jiangsu Hansoh Pharmaceutical Co., Ltd. | Phase 1 / Phase 2 |
| Terminated | Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures: an Observational Study NCT05961163 | Universitätsklinikum Hamburg-Eppendorf | — |
| Recruiting | Restoring Spindle and Thalamocortical Efficiency in Early-Course Schizophrenia Patients Using Auditory Stimula NCT05956951 | Fabio Ferrarelli | N/A |
| Unknown | SUCCEED Africa: Support, Comprehensive Care and Empowerment of People With Psychosocial Disabilities NCT06007105 | London School of Hygiene and Tropical Medicine | N/A |
| Unknown | Bizarreness and Anomalous Self Experiences in Schizophrenia NCT05966610 | University Hospital, Toulouse | — |
| Recruiting | Critical Time Intervention-Peer Support NCT05945277 | Lisbon Institute of Global Mental Health - LIGMH | N/A |
| Unknown | rTMS for Auditory Hallucinations Guided by Magnetoencephalography NCT05598450 | Shanghai Mental Health Center | N/A |
| Not Yet Recruiting | A Study of the Efficacy of Fecal Microbiota Transplantation(FMT) in the Treatment of Schizophrenia NCT05850585 | First Affiliated Hospital Xi'an Jiaotong University | N/A |
| Active Not Recruiting | Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders NCT05838560 | Washington University School of Medicine | Phase 2 |
| Completed | Music Therapy to Reduce Anxiety in Community-Dwelling Individuals With Severe Mental Illness NCT06315049 | Universitat Politècnica de València | N/A |
| Completed | A Trial to Assess a Wearable Patch's Functioning to Detect Medication Ingestion NCT06372210 | Otsuka Pharmaceutical Development & Commercialization, Inc. | N/A |
| Completed | A Study To Evaluate The Effect Of A Supratherapeutic Dose Of MK-8189 On The QTc Interval In Participants With NCT05893862 | Merck Sharp & Dohme LLC | Phase 1 |
| Completed | A Clinical Study to Learn if SEP-363856 Has Physical Dependence in Adults With Schizophrenia NCT05848700 | Otsuka Pharmaceutical Development & Commercialization, Inc. | Phase 1 |
| Completed | Contingency Management for Problematic Behavior Reduction in the Community NCT06486584 | Laureate Institute for Brain Research, Inc. | N/A |
| Completed | Network-Targeted Neuromodulation for Nicotine Dependence in Schizophrenia NCT06389266 | Vanderbilt University Medical Center | N/A |
| Recruiting | Treatment of Negative Symptoms of Schizophrenia by rTMS NCT06595654 | Centre hospitalier de Ville-Evrard, France | N/A |
| Completed | Comparison of Physical Fitness, Physical Activity Level in Patients With Bipolar Disorder and Schizophrenia NCT05936983 | Yeditepe University | — |
| Not Yet Recruiting | tDCS for Cognitive Impairment Associated With Recent-onset Schizophrenia NCT05440955 | University Hospital, Grenoble | N/A |
| Unknown | Adapting the Tumor Board Model for Mental Illness and Cancer NCT05837598 | Massachusetts General Hospital | N/A |
| Active Not Recruiting | EPI-MINN: Targeting Cognition and Motivation - National NCT05877716 | University of Minnesota | N/A |
| Recruiting | EEG Microstates Across At-Risk Mental States NCT06045897 | Centre Hospitalier St Anne | N/A |
| Completed | Motivation Skills Training for Schizophrenia NCT05746455 | Columbia University | N/A |
| Completed | A Study to Assess the Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Chinese Adult Subjects Wi NCT05919823 | Karuna Therapeutics, Inc., a Bristol Myers Squibb company | Phase 3 |
| Completed | Comparison of the Effects of Physical Activity and Virtual Reality Training in Patients With Schizophrenia NCT07173465 | Yeditepe University | N/A |
| Recruiting | Safety and Tolerability of Open-Labeled Iloperidone in Adolescents NCT05648591 | Vanda Pharmaceuticals | Phase 4 |
| Recruiting | Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Epi NCT05890183 | University of California, Los Angeles | N/A |
| Completed | Clozapine Hematological Monitoring Regulatory Compliance Assessment in Psychiatry NCT06610500 | Centre Hospitalier Universitaire de Saint Etienne | — |
| Completed | Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tar NCT05859698 | Neurocrine Biosciences | Phase 4 |
| Recruiting | Metformin Treatment on Cognitive Impairment of Schizophrenia NCT05838573 | Central South University | Phase 3 |
| Recruiting | iTBS to Enhance Social Cognition in People With Psychosis NCT06118268 | Northwell Health | N/A |
| Recruiting | Promoting Cognitive Health in Schizophrenia NCT05661448 | Douglas Mental Health University Institute | N/A |
| Withdrawn | Lost Children Society (LCS), Online Therapeutic Tabletop Role-playing Game for Early-onset Schizophrenia Patie NCT05469815 | Centre Hospitalier Departemental Vendee | N/A |
| Completed | Study to Evaluate the Pharmacokinetics (PK) and Safety/Tolerability of Long-Acting Oral LYN-005 NCT05779241 | Lyndra Inc. | Phase 3 |
| Recruiting | EEG and Behavioral Correlates of Temporal Prediction in the Tactile Modality in Schizophrenia NCT05296720 | Centre Psychothérapique de Nancy | N/A |
| Completed | Cinematic Virtual Reality Intervention for Improving Psychosocial Functioning in Individuals With Schizophreni NCT07326618 | Dokuz Eylul University | N/A |
| Completed | Focused Ultrasound Modulation of the Globus Pallidus Interna in Schizophrenia NCT05643196 | NYU Langone Health | Phase 2 |
| Recruiting | Deep rTMS Modulating Insula Synaptic Density and Smoking Behavior in Schizophrenia NCT05724810 | Stony Brook University | N/A |
| Recruiting | COMpassion for Psychiatric Disorders And Self-Stigma NCT05698589 | University Hospital, Strasbourg, France | N/A |
| Unknown | Tele-group Cognitive Behavioural Family Intervention (tgCBFI) for People With Schizophrenia and Their Families NCT05808244 | The Hong Kong Polytechnic University | N/A |
| Recruiting | Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in Schizophrenia NCT05748990 | Centre for Addiction and Mental Health | N/A |
| Completed | Personalized Dual-target RTMS for Patients with Refractory Schizophrenia NCT06732817 | Anhui Medical University | N/A |
| Completed | An Extension Study to a Clinical Study That Will Continue to Evaluate the Effectiveness and Safety of SEP-3638 NCT05741528 | Otsuka Pharmaceutical Development & Commercialization, Inc. | Phase 3 |
| Completed | Study of Two Digital Therapeutics for the Treatment of Experiential Negative Symptoms of Schizophrenia NCT05838625 | Click Therapeutics, Inc. | Phase 3 |
| Completed | Motivational Interviewing for Patients With Acute Psychosis NCT05911529 | Psychiatric University Hospital, Zurich | N/A |
| Completed | The Effect of Social Skills Intervention on Praxis and Social Functioning in Individuals With Schizophrenia NCT05901922 | Nigde Omer Halisdemir University | N/A |
| Completed | Effects of Psyllium on Constipation in Schizo-phrenic: A Randomized Controlled Crossover Trial NCT05528146 | Hungkuang University | N/A |
| Recruiting | Outcomes From Remediation and Behavioural Intervention Techniques NCT05731414 | University of Toronto | N/A |
| Recruiting | Examining tDCS Effect on Cannabis Use Disorder in Patients With Schizophrenia NCT04871048 | Centre Hospitalier Universitaire de Saint Etienne | N/A |
| Enrolling By Invitation | Effectiveness of mHealth Post-discharge Intervention for Patients With Severe Mental Illness NCT05703412 | Butler Hospital | N/A |
| Recruiting | Prebiotic Treatment in People With Schizophrenia NCT05527210 | University of Maryland, Baltimore | N/A |
| Completed | A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label, Long-Term Safety Phase to Evaluate th NCT05693935 | Teva Branded Pharmaceutical Products R&D LLC | Phase 3 |
| Completed | The Effect of Recognition and Expression of Emotions Program Applied to Schizophrenia Patients NCT05662137 | Sinop University | N/A |
| Recruiting | Estimating Prevalence of Inherited Disorders of Sulfur Amino Acids Metabolism in Patients With Psychotic Disor NCT05206292 | University Hospital, Grenoble | N/A |
| Completed | Risk of Breakthrough Symptoms With Long-Acting Injectable Medications NCT05473741 | Centre for Addiction and Mental Health | — |
| Completed | TMS Related Biomarker Assessments NCT05660018 | University of Maryland, Baltimore | N/A |
| Terminated | Study to Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as an Adjunctive Treatment for Schizop NCT05654870 | Neurocrine Biosciences | Phase 3 |
| Recruiting | Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services NCT06740383 | Beth Israel Deaconess Medical Center | — |
| Completed | Cognitive Effects of tDCS and tRNS in Schizophrenia NCT06155786 | The National Brain Mapping Laboratory (NBML) | N/A |
| Unknown | Characterizing Response to Antipsychotics in Schizophrenia NCT06159322 | The Royal Ottawa Mental Health Centre | — |
| Unknown | A Study on the Efficacy of Agomelatine Combined With Antipsychotics to Treat Negative Symptoms in Schizophreni NCT05646264 | Shanghai Mental Health Center | Phase 4 |
| Completed | A Clinical Study That Will Evaluate How Well SEP-363856 Works and How Safe it is in People With Schizophrenia NCT05628103 | Otsuka Pharmaceutical Development & Commercialization, Inc. | Phase 3 |
| Completed | Vısual Arts Group Therapy Based On Watson's Human Care Model In Indıvıduals Wıth Schızophrenıa NCT05954208 | Gazi University | N/A |
| Completed | A Study to Evaluate RL-007 in the Treatment of Cognitive Impairment Associated With Schizophrenia (CIAS) NCT05686239 | Recognify Life Sciences | Phase 2 |
| Suspended | D-serine AudRem: R33 Phase NCT05046353 | New York State Psychiatric Institute | Phase 1 / Phase 2 |
| Recruiting | Acceptability and Feasibility of Work-Oriented Social-Cognitive Skills Training for Veterans With Serious Ment NCT05491538 | VA Office of Research and Development | N/A |
| Not Yet Recruiting | fMRI-based Neurofeedback to Relieve Drug-resistant Auditory Hallucinations NCT04798131 | University Hospital, Lille | N/A |
| Unknown | Accelerated TMS in Psychosis NCT05567848 | Beth Israel Deaconess Medical Center | Phase 1 / Phase 2 |
| Completed | The Efficacy of Neural Stimulation in Individuals With Schizophrenia NCT05746494 | The University of Texas at Dallas | N/A |
| Completed | Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III NCT05658510 | BioXcel Therapeutics Inc | Phase 3 |
| Completed | A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Bod NCT05542264 | Otsuka Pharmaceutical Development & Commercialization, Inc. | Phase 1 |
| Recruiting | Study on the Role and Mechanism of Plasma Exosome microRNAs in Cognitive Impairment in First-episode Schizophr NCT07139171 | Tianjin Anding Hospital | — |
| Terminated | An Open-label Study to Assess the Long-term Safety, Tolerability, Effectiveness, and Durability of Effect of K NCT05643170 | Karuna Therapeutics, Inc., a Bristol Myers Squibb company | Phase 3 |
| Completed | The Effectiveness and Efficacy of the Combination of the Integrated Psychological Therapy and Metacognitive Tr NCT05623228 | Rakitzi, Stavroula | Phase 2 |
| Completed | Service User and Staff Views on Digital Remote Monitoring for Psychosis NCT05670197 | Manchester Academic Health Science Centre | — |